Trial intelligence / Profile preview

Landiolol in Out-of-Hospital Cardiac Arrest (Beta-Arrest)

NCT05554978Phase 2Unknown

Sponsor
Medical University of Vienna
Start
Mar 2021
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in cardiac arrest (SCA) comparing Landiolol Arm with Placebo Arm (2 arms). Primary endpoint: Time to sustained return of spontaneous circulation. Status: unknown.

02

Drugs

landiolol
03

Conditions

cardiac arrest (SCA)

Beyond the preview

Go deeper on NCT05554978.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05554978.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call